ACTION-Grid

ACTION-Grid is a Specific International Cooperation Project on healthcare information systems based on Grid capabilities and Biomedical Informatics (BMI) between Latin America, the Western Balkans and the European Union (EU). Members of the consortium have published pioneering scientific papers in Grid and BMI. They participated in the BIOINFOMED and SYMBIOMATICS studies that contributed decisively to the last two FPs of the EC.

ACTION-Grid will act as a multiplier of previous outcomes in Grid and BMI. ACTION-Grid will disseminate these outcomes in Latin America, the Western Balkans and North Africa.

Subobjectives:

  • To survey Grid-based and BMI initiatives in Europe, Latin America, the Western Balkans and North Africa. These results will be combined with data from an inventory of Grid/Nano/BMI methods and services-, developed by the consortium.
  • Based on previous EC-based projects, ACTION-Grid will foster training and mobility in Grid and BMI.
  • To develop a White Paper, in collaboration with a panel of recognized experts. This document will be delivered to the EC to establish a future agenda covering the Grid/Nano/Bio/Medical Informatics areas and develop new plans in Latin America, the Western Balkans and North Africa.
  • To disseminate ACTION-Grid, by means of:
    • An international symposium on Grid and BMI. This conference will be carried out in Europe, with two satellite conferences
    • Scientific publications,
    • Dissemination strategies, such as a Website, Newsletters, Press releases, etc.

To expand previous initiatives to create a common health information infrastructure in Europe, and extending it to other regions. It will enhance cooperation between research centres, universities, hospitals, SMEs, public entities, and others. ACTION-Grid will expand the impact of EC achievements in Grid and BMI to researchers, educators, and health practitioners' world-wide.

For further information, please visit:
http://www.action-grid.eu

Project co-ordinator:
Universidad Politécnica de Madrid

Partners:

  • Universidad de Talca
  • Sveučilište u Zagrebu Medicinski fakultet
  • Foundation for Research and Technology - Hellas
  • Instituto de Salud Carlos III
  • HealthGrid
  • Sociedad Italiana de Beneficencia en Buenos Aires

Timetable: from 06/2008 – to 11/2009

Total cost: € 1.118.402

EC funding: € 999.077

Programme Acronym: FP7-ICT

Subprogramme Area: Virtual physiological human

Contract type: Coordination and support actions

Related news article:

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...